Darbepoetin alfa for the treatment of anaemia in alpha‐ or beta‐ thalassaemia intermedia syndromes

Alter, B.P. (2003) Cancer in Fanconi anemia, 1927– 2001. Cancer, 97, 425–440. Baron, F., Sybert, V.P. & Andrews, R.G. (1989) Cutaneous and extracutaneous neutrophilic infiltrates (Sweet syndrome) in three patients with Fanconi anemia. Journal of Pediatrics, 115, 726–729. Briot, D., Mace-Aime, G., Subra, F. & Rosselli, F. (2008) Aberrant activation of stress-response pathways leads to TNF-alpha oversecretion in Fanconi anemia. Blood, 111, 1913–1923. Buck, T., Gonzalez, L.M., Lambert, W.C. & Schwartz, R.A. (2008) Sweet’s syndrome with hematologic disorders: a review and reappraisal. International Journal of Dermatology, 47, 775–782. Chatham-Stephens, K., Devere, T., Guzman-Cottrill, J. & Kurre, P. (2008) Metachronous manifestations of Sweet’s syndrome in a neutropenic patient with Fanconi anemia. Pediatric Blood & Cancer, 51, 128–130. Guhl, G. & Garcia-Diez, A. (2008) Subcutaneous sweet syndrome. Dermatologic Clinics, 26, 541–551. viii–ix. Hospach, T., von den Driesch, P. & Dannecker, G.E. (2009) Acute febrile neutrophilic dermatosis (Sweet’s syndrome) in childhood and adolescence: two new patients and review of the literature on associated diseases. European Journal of Pediatrics, 168, 1–9. McDermott, M.B., Corbally, M.T. & O’ Marcaigh, A.S. (2001) Extracutaneous Sweet syndrome involving the gastrointestinal tract in a patient with Fanconi anemia. Journal of Pediatric Hematology/oncology, 23, 59–62. Vardiman, J.W., Thiele, J., Arber, D.A., Brunning, R.D., Borowitz, M.J., Porwit, A., Harris, N.L., Le Beau, M.M., Hellström-Lindberg, E., Tefferi, A. & Bloomfield, C.D. (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood, 114, 937–951. Vignon-Pennamen, M.D., Juillard, C., Rybojad, M., Wallach, D., Daniel, M.T., Morel, P., Verola, O. & Janin, A. (2006) Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases. Archives of Dermatology, 142, 1170–1176.

[1]  T. Peto,et al.  Age-related changes in adaptation to severe anemia in childhood in developing countries , 2007, Proceedings of the National Academy of Sciences.

[2]  N. Tatsumi,et al.  Recent advances in diagnosis of paragonimiasis. , 1997 .

[3]  D. Perry,et al.  Sustained increase in haemoglobin and RBC following long‐term administration of recombinant human erythropoietin to patients with homozygous beta‐thalassaemia , 1995, British journal of haematology.

[4]  E. Cassinerio,et al.  Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia: case reports and literature review , 2008, International journal of laboratory hematology.

[5]  J. Georgiou,et al.  Administration of high doses of recombinant human erythropoietin to patients with β‐thalassemia intermedia: a preliminary trial , 1997, European journal of haematology.

[6]  S. Perrine.  Fetal Globin Induction—Can It Cure β Thalassemia? , 2005 .

[7]  G. Barosi,et al.  Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients. , 1994, Blood.

[8]  J. Čermák.  Erythropoietin Administration May Potentiate Mobilization of Storage Iron in Patients on Oral Iron Chelation Therapy , 2006, Hemoglobin.

[9]  G. Mantovani,et al.  Use of erythropoiesis stimulating agents for the treatment of anaemia and related fatigue in a pregnant woman with HbH disease , 2009, British journal of haematology.

[10]  G. Kudva,et al.  Erythropoietin for hemoglobin H disease , 2009, Annals of Hematology.

[11]  S. Perrine.  Fetal globin induction--can it cure beta thalassemia? , 2005, Hematology. American Society of Hematology. Education Program.

[12]  N. Tatsumi,et al.  Difference in pattern of erythropoietin response between beta-thalassemia/hemoglobin E children and adults. , 1997, Southeast Asian Journal of Tropical Medicine and Public Health.